國家衛生研究院 NHRI:Item 3990099045/7144
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 860499      線上人數 : 665
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/7144


    題名: GFBP5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder
    作者: Liang, PI;Huang, HY;Li, CF
    貢獻者: National Institute of Cancer Research
    摘要: Background: Urothelial carcinoma (UC) is a prevalent cancer worldwide, especially in developed country. Although urinary bladder urothelial carcinoma (UBUC) is more common than upper urinary tract urothelial carcinoma (UTUC), tumorigenesis of urothelial carcinoma arising from these two areas may share a similar pathway. Dysregulation of cell growth is critical for tumorigenesis but has not been assessed systemically in UC. Data mining of the published UBUC dataset (GSE31684) identified insulin-like growth factor binding protein 5 (IGFBP5) as the most significantly upregulated genes that associated with regulation of cell growth. Besides, IGFBP5 transcript expression level also significantly predicted worse outcome. We therefore analyze IGFBP5 expression and its associations with clincopathological factors and survivals in our well-characterized cohort of UC.Design: IGFBP5 immunostain was performed on 340 cases of upper urinary tract urothelial carcinoma (UTUC) and 295 cases of UBUC. The result of IGFBP5 expression was then correlated with various clincopathological factors disease-specific survival (DSS), and metastasis-free survival (MeFS). Western blot analysis was used to evaluate IGFBP5 protein expression in human urothelial cancer cell lines.Results: In both group of tumors, IGFBP5 overexpression significantly associated with advanced pT stage (both p<0.001), high histological grade (UTUC, p<0.001; UBUC, p=0.035), lymph node metastasis (UTUC, p=0.006; UBUC, p=0.004), vascular invasion (UTUC, p<0.001; UBUC, p=0.003), perineurial invasion (UTUC, p=0.034; UBUC, p=0.021) and frequent mitosis (UTUC, p<0.001; UBUC, p=0.023). IGFBP5 overexpression also independently predicted poor DSS (UTUC, p < 0.0001; UBUC, p = 0.0001) and MeFS (both p < 0.0001) in both groups of patients. IGFBP5 protein was abundant in urothelial cancer cell lines but barely detected in benign urothelial cells.Conclusions: IGFBP5 overexpression is associated with advanced tumor stage and conferred poorer clinical outcome. Our study suggested that IGFBP5 plays an important role in tumor progression in UC, justifying the potentiality of IGFBP5 as a prognostic biomarker and a novel therapeutic target of UC.
    日期: 2013-02
    關聯: Modern Pathology. 2013 Feb;26(Suppl. 2):230A.
    Link to: http://dx.doi.org/10.1038/modpathol.2013.11
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0893-3952&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000314444401359
    顯示於類別:[其他] 會議論文/會議摘要

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    ISI000314444401359.pdf1778KbAdobe PDF588檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋